BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,297,573 | -28.6% | 100,720 | +1.1% | 0.37% | -29.7% |
| Q2 2023 | $4,621,071 | +18.6% | 99,635 | +9.2% | 0.52% | +16.9% |
| Q1 2023 | $3,894,918 | -3.1% | 91,280 | +2.4% | 0.45% | -1.5% |
| Q4 2022 | $4,019,774 | -18.9% | 89,150 | -1.1% | 0.46% | -26.3% |
| Q3 2022 | $4,957,000 | -18.0% | 90,128 | -5.5% | 0.62% | -10.8% |
| Q2 2022 | $6,047,000 | -18.1% | 95,347 | +0.9% | 0.69% | -3.5% |
| Q1 2022 | $7,380,000 | -8.9% | 94,527 | +0.9% | 0.72% | -7.7% |
| Q4 2021 | $8,097,000 | +8.7% | 93,672 | +1.2% | 0.78% | +0.8% |
| Q3 2021 | $7,447,000 | -0.2% | 92,597 | +1.4% | 0.77% | +1.0% |
| Q2 2021 | $7,463,000 | -0.2% | 91,282 | +3.3% | 0.76% | -10.4% |
| Q1 2021 | $7,480,000 | +9.6% | 88,372 | +5.1% | 0.85% | -7.3% |
| Q4 2020 | $6,827,000 | +4.8% | 84,057 | +3.3% | 0.92% | -7.9% |
| Q3 2020 | $6,512,000 | +33.4% | 81,362 | +2.1% | 1.00% | +6.0% |
| Q2 2020 | $4,881,000 | +12.7% | 79,662 | +1.7% | 0.94% | -9.5% |
| Q1 2020 | $4,331,000 | -38.1% | 78,367 | -0.0% | 1.04% | +18.8% |
| Q4 2019 | $6,993,000 | +13.5% | 78,387 | +7.2% | 0.88% | +6.6% |
| Q3 2019 | $6,159,000 | +5.3% | 73,118 | +2.6% | 0.82% | +6.6% |
| Q2 2019 | $5,847,000 | +10.6% | 71,253 | +0.2% | 0.77% | +9.3% |
| Q1 2019 | $5,285,000 | +12.7% | 71,103 | +0.3% | 0.71% | +3.1% |
| Q4 2018 | $4,689,000 | -11.8% | 70,913 | -2.7% | 0.68% | -5.6% |
| Q3 2018 | $5,318,000 | -15.5% | 72,868 | -14.3% | 0.73% | -14.2% |
| Q2 2018 | $6,294,000 | +8.4% | 85,038 | -3.8% | 0.85% | +3.7% |
| Q1 2018 | $5,807,000 | -7.2% | 88,363 | -1.2% | 0.82% | -0.4% |
| Q4 2017 | $6,259,000 | +8.5% | 89,398 | -1.5% | 0.82% | +3.3% |
| Q3 2017 | $5,770,000 | +4.1% | 90,730 | +0.4% | 0.79% | -0.5% |
| Q2 2017 | $5,542,000 | +14.5% | 90,405 | -1.9% | 0.80% | +15.3% |
| Q1 2017 | $4,840,000 | +10.6% | 92,144 | -5.2% | 0.69% | +9.7% |
| Q4 2016 | $4,377,000 | -11.1% | 97,149 | -4.8% | 0.63% | -28.7% |
| Q3 2016 | $4,924,000 | +6.5% | 102,029 | +0.9% | 0.88% | +2.4% |
| Q2 2016 | $4,622,000 | +10.2% | 101,124 | +1.1% | 0.86% | +10.6% |
| Q1 2016 | $4,196,000 | +15.1% | 99,984 | +3.6% | 0.78% | +2.9% |
| Q4 2015 | $3,645,000 | +22.0% | 96,514 | +4.6% | 0.76% | +22.9% |
| Q3 2015 | $2,987,000 | +0.5% | 92,244 | +19.1% | 0.62% | +10.6% |
| Q2 2015 | $2,972,000 | -50.9% | 77,459 | +8.7% | 0.56% | -38.9% |
| Q1 2015 | $6,058,000 | +3.9% | 71,239 | +4.3% | 0.91% | -3.8% |
| Q4 2014 | $5,832,000 | +10.1% | 68,279 | +5.5% | 0.95% | +7.7% |
| Q3 2014 | $5,296,000 | +30.8% | 64,729 | +19.4% | 0.88% | +24.3% |
| Q2 2014 | $4,049,000 | +7.3% | 54,214 | +4.9% | 0.71% | -1.4% |
| Q1 2014 | $3,773,000 | – | 51,659 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |